HNGE shareholder (HNGE) plans Rule 144 stock sale and reports 10b5-1 trades

Rhea-AI Filing Summary

A security holder of HNGE has filed a notice of proposed sale under Rule 144 for 166,665 shares of common stock, with an aggregate market value of $7,593,257.40. The filing lists Morgan Stanley Smith Barney LLC as broker, notes that 37,919,155 shares of this class were outstanding, and indicates an approximate sale date of January 5, 2026 on the NYSE.

The shares were acquired on March 22, 2023 through restricted stock awards from the issuer in the same amount. The document also reports prior Rule 10b5-1 sales for Daniel Perez of 166,670 shares of common stock on December 15, 2025 for gross proceeds of $8,088,311.76. By signing, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s operations.

FAQ

What does the HNGE Form 144 notice disclose?

It discloses a planned Rule 144 sale of 166,665 shares of HNGE common stock, with an aggregate market value of $7,593,257.40, through a broker on the NYSE.

How many HNGE shares are planned to be sold and when?

The notice covers 166,665 common shares, with an approximate sale date of January 5, 2026 on the NYSE.

How and when were the HNGE shares to be sold under Rule 144 acquired?

The 166,665 shares were acquired from the issuer on March 22, 2023 via restricted stock awards, with the same amount shown as acquired on that date.

What prior HNGE share sales by this person are reported in the past 3 months?

The filing reports 10b5-1 sales for Daniel Perez of 166,670 common shares on December 15, 2025, with $8,088,311.76 in gross proceeds.

How many HnGE common shares were outstanding for this class?

The notice states that 37,919,155 shares of the relevant class of HNGE common stock were outstanding.

What representation does the seller make about HNGE in the Rule 144 notice?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/05/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002063236
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	DANIEL PEREZ
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	166665	7593257.40	37919155	01/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/22/2023	Restricted Stock Awards	Issuer			166665	03/22/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL PEREZ 455 Market Street, Suite 700 San Francisco CA 94105	Common	12/15/2025	166670	8088311.76

144: Remarks and Signature

Remarks
Date of Notice	01/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Perez
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)